Correlation Between Spero Therapeutics and Dominari Holdings
Can any of the company-specific risk be diversified away by investing in both Spero Therapeutics and Dominari Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spero Therapeutics and Dominari Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Spero Therapeutics and Dominari Holdings, you can compare the effects of market volatilities on Spero Therapeutics and Dominari Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spero Therapeutics with a short position of Dominari Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spero Therapeutics and Dominari Holdings.
Diversification Opportunities for Spero Therapeutics and Dominari Holdings
0.12 | Correlation Coefficient |
Average diversification
The 3 months correlation between Spero and Dominari is 0.12. Overlapping area represents the amount of risk that can be diversified away by holding Spero Therapeutics and Dominari Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dominari Holdings and Spero Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spero Therapeutics are associated (or correlated) with Dominari Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dominari Holdings has no effect on the direction of Spero Therapeutics i.e., Spero Therapeutics and Dominari Holdings go up and down completely randomly.
Pair Corralation between Spero Therapeutics and Dominari Holdings
Given the investment horizon of 90 days Spero Therapeutics is expected to generate 0.74 times more return on investment than Dominari Holdings. However, Spero Therapeutics is 1.35 times less risky than Dominari Holdings. It trades about 0.01 of its potential returns per unit of risk. Dominari Holdings is currently generating about -0.02 per unit of risk. If you would invest 117.00 in Spero Therapeutics on August 27, 2024 and sell it today you would lose (1.00) from holding Spero Therapeutics or give up 0.85% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Spero Therapeutics vs. Dominari Holdings
Performance |
| Timeline |
| Spero Therapeutics |
| Dominari Holdings |
Spero Therapeutics and Dominari Holdings Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Spero Therapeutics and Dominari Holdings
The main advantage of trading using opposite Spero Therapeutics and Dominari Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spero Therapeutics position performs unexpectedly, Dominari Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dominari Holdings will offset losses from the drop in Dominari Holdings' long position.| Spero Therapeutics vs. Eliem Therapeutics | Spero Therapeutics vs. HCW Biologics | Spero Therapeutics vs. Scpharmaceuticals | Spero Therapeutics vs. Milestone Pharmaceuticals |
| Dominari Holdings vs. Eliem Therapeutics | Dominari Holdings vs. HCW Biologics | Dominari Holdings vs. Scpharmaceuticals | Dominari Holdings vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |